LSA
XENE icon

Leonteq Securities AG’s Xenon Pharmaceuticals XENE Stock Holding History

Leonteq Securities AG’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-530
Closed -$20.4K – 1301
2023
Q2 		$20.4K Hold
530
– – ﹤0.01% 963
2023
Q1 		$19K Hold
530
– – ﹤0.01% 929
2022
Q4 		$20.9K Hold
530
– – ﹤0.01% 958
2022
Q3 		$19.1K Hold
530
– – ﹤0.01% 961
2022
Q2 		$16.1K Hold
530
– – ﹤0.01% 1011
2022
Q1 		$16.2K Hold
530
– – ﹤0.01% 1034
2021
Q4 		$16.6K Buy
+530
New +$15.8K ﹤0.01% 1082

Other funds holding XENE

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Leonteq Securities AG's XENE Position: Q3 2023 in Review

Leonteq Securities AG sold out of Xenon Pharmaceuticals (XENE) in Q3 2023, closing a stake of 530 shares — an estimated $20.4K sold.

Leonteq Securities AG first reported a position in XENE in Q4 2021 and held it in 7 quarters. The position peaked at $20.9K in Q4 2022. 180 funds tracked by Wall St. Rank hold XENE as of Q3 2023.

  • Leonteq Securities AG reported no remaining Xenon Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Leonteq Securities AG sold 530 Xenon Pharmaceuticals shares in Q3 2023, an estimated $20.4K.
  • Leonteq Securities AG first reported a position in Xenon Pharmaceuticals in Q4 2021 and held it in 7 quarters.
  • Leonteq Securities AG's Xenon Pharmaceuticals position peaked at $20.9K in Q4 2022.
  • 180 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q3 2023.

Based on Leonteq Securities AG's 13F filing for Q3 2023, filed 11 Mar 2026.